[Diabetic with hallucination].
Saloranta
Carola
C
HYKS:N diabetesklinikka, HUS.
Tuomi
Tiinamaija
T
D001262:Atenolol / Q000009:adverse effects* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D018570:Risk Assessment
D001262:Atenolol